ASCI: Antigen Specific Cancer Immunotherapeutics
ASCI (Antigen-Specific Cancer Immunotherapeutics) is a new type of immunotherapy in development that targets cancer antigens and potentially destroys the cancer cells that bear these antigens.
This approach to cancer treatment may have several advantages:
- ASCI is a tumor-specific targeted approach.
- ASCI is a potential treatment for a wide range of cancer types.
- ASCI can potentially be used for treating different stages of cancer disease.
- ASCI may produce fewer side effects because it is envisioned that it should not affect normal healthy cells in the body.
